ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976

DCT Board Okays Six Contract Recompetitions

October 23, 1987